SDR16C6, which stands for "Short Chain Dehydrogenase/Reductase Family 16C, Member 6," is part of the SDR family of enzymes. It is characterized by its role in oxidoreduction reactions where it catalyzes the NAD(P)(H)-dependent oxidation or reduction of substrates with a relatively short-chain length. SDR16C6, like other members of the SDR family, is involved in a myriad of metabolic processes which can include the metabolism of steroids, fatty acids, and xenobiotics.The SDR enzymes are known for their conserved structural motif, often referred to as the Rossmann fold, which is essential for binding the coenzyme NAD(P)(H). This motif is a key feature that allows these enzymes to participate in the electron transfer required for their catalytic activity. The precise function of SDR16C6, in terms of its specific substrates and biological roles, is not as well characterized as other members of the SDR family.
Nevertheless, the enzymatic activity of SDR16C6 suggests it may play a role in the metabolism of hormones or signaling molecules, contributing to the regulation of various physiological pathways. Changes in the expression or activity of SDR16C6 could feasibly influence metabolic balance, and an understanding of its function might shed light on certain metabolic disorders or contribute to the development of drugs targeting specific metabolic pathways.It's also important to note that SDR enzymes, in general, can be subject to regulation by various cellular factors and might be involved in the cellular response to external stimuli, including drugs and environmental factors. As such, SDR16C6 may also be part of the broader network of enzymes that help maintain cellular homeostasis by modulating metabolic pathways in response to changing cellular needs and conditions.
VOIR ÉGALEMENT...
| Nom du produit | CAS # | Ref. Catalogue | Quantité | Prix HT | CITATIONS | Classement |
|---|---|---|---|---|---|---|
Metformin | 657-24-9 | sc-507370 | 10 mg | $77.00 | 2 | |
Un médicament antidiabétique qui module le métabolisme du glucose, influençant potentiellement les voies liées à SDR16C6. | ||||||
Anticorps Insulin () | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $153.00 $1224.00 $12239.00 | 82 | |
En tant que régulateur clé du métabolisme du glucose et des lipides, l'insuline pourrait indirectement affecter l'activité de SDR16C6. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $54.00 $123.00 | 13 | |
Agoniste PPARγ, il influence le métabolisme des lipides et du glucose, ce qui pourrait avoir un impact sur le SDR16C6. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $118.00 $320.00 $622.00 $928.00 $1234.00 | 38 | |
Un autre agoniste PPARγ, modifie le métabolisme des lipides et du glucose, ce qui pourrait affecter le SDR16C6. | ||||||
Acarbose | 56180-94-0 | sc-203492 sc-203492A | 1 g 5 g | $222.00 $593.00 | 1 | |
Inhibiteur de l'alpha-glucosidase, affecte le métabolisme des hydrates de carbone, influençant potentiellement SDR16C6. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $40.00 | 9 | |
En tant qu'agoniste PPARα, le fénofibrate module le métabolisme des lipides, affectant potentiellement SDR16C6. | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $61.00 $122.00 | 1 | |
Influence le métabolisme des lipides, avec un impact potentiel sur les voies liées à SDR16C6. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $252.00 $495.00 | 9 | |
Une statine qui affecte le métabolisme du cholestérol, ayant un impact potentiel sur SDR16C6. | ||||||
Lipase Inhibitor, THL | 96829-58-2 | sc-203108 | 50 mg | $51.00 | 7 | |
Inhibe la lipase, ce qui a un impact sur la digestion et l'absorption des lipides, influençant potentiellement SDR16C6. | ||||||